The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world
News
We are proud to introduce KD LabServiceTM, Omega-3 Testing Laboratory and Analytics.
News
BIOGGIO, SWITZERLAND – July 18, 2024 – The KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, and dsm-firmenich, innovators in nutrition, health, and beauty, announce today t
News
We are pleased to announce that our manufacturing site in Bexbach, Germany, has achieved the V-Label VEGAN Certification for our algal oils.
News
BIOGGIO, SWITZERLAND – June 1, 2023 – We are delighted to announce the collaboration between KD Pharma Group, a leading European chemical CDMO service provider, and DUDE CH
News
New Research discusses the benefits of cannabis treatment for multiple symptoms including pain.
Latest Findings
“We need a precision medicine approach” (Quoted from Dr. Maurizio Fava)
News
We are very proud to announce that our Quality Control team in KD Pharma Bexbach, Germany, has achieved the first place in the AOCS Laboratory Proficiency Program for GOED Nutraceu
News
Environmental impact and sustainability have always played an important role in the KD Pharma Group's approach to business.
Latest Findings
Have a look at the last scientific studies about Omega-3s in the links below:
News
We are pleased to announce the opening of our new R&D laboratory and offices at our world-class synthesis and fractionation facility in Seal Sands, UK.
News
KD Pharma is a very dynamic, fast-growing company, that is constantly enlarging its technology toolbox for chemical transformations, purification and separation, and encapsulation under cGMP.
News
BIOGGIO, SWITZERLAND – October 18, 2021 – The KD Pharma Group has completed an expansion of its manufacturing site in Seal Sands, United Kingdom.
News
BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of me
News
BIOGGIO, SWITZERLAND – September 30, 2021 – The KD Pharma Group today announced the appointment of Daniel Wiley as Vice President of Special Projects with responsibility to lead growth projects in
Trade Fairs
KD Pharma world-class cGMP synthesis and fractionation facility in the UK has a long track record in manufacturing exceptional quality APIs.
News
Transaction advances KD Pharma’s cannabinoid manufacturing strategy
News
Acquisition expands KD Pharma’s CDMO capabilities
Clinicals
News
BIOGGIO, SWITZERLAND – August 5, 2020 – KD Pharma Group SA and Stratum Nutrition® announce their recent partn
News
Bexbach, GERMANY – March 30, 2020 – As the Novel Coronavirus outbreak spreads across the world, KD Pharma Bex
News
BIOGGIO, SWITZERLAND – April 14, 2020 – The KD Pharma Group (“KD Pharma”) and its partner, SLA Pharma (“SLA”), announced that its new drug candidate EPAspire
News
Capiton AG closes single-asset secondary transaction of KD Pharma Group SA and raises new single-asset fund.
News
Acquisition allows KD Pharma to further expand its leading position in the omega-3 pharmaceutical market
News
The KD Pharma Group has rearranged and expanded its debt facilities, raising €150 million in total financing through the facilities.
News
Omega-3 and sports performance – Clinically proven formula Move3™ improves pain, stiffness and cartilage damage related to exercise
News
Omega-3 fatty acids are essential and can only be obtained from the diet. However, the standard western diet is severely deficient in these critical nutrients.
News
Choline and DHA Omega3 fatty acid have been both studied for their importance on early neural development.
News
Beginning on November 1, 2018, Marine Ingredients and InnovaGel combined systems to become a unified brand called KD Nutra.
Latest Findings
Vitamin D and Omega-3 TriaL (VITAL Study):
VITAL investigated whether taking daily vitamin D3 and/or EPA+DHA (omega-3-acid ethyl esters) reduces the risk of major cardiovascular disease (
News
Building on the substantial health benefits of EPA and DHA Omega-3 fatty acids, ReGen3™ is an enhanced marine lipid concentrate with enriched levels of pre-resolving mediators (PRMs) that may offer
News
Omega-3 innovation: KD Pharma launches DPA and PRM ingredients
News
A company’s success or failure certainly can float on the product category a business is in, but at the end of the day it’s people that run the business, and top-shelf people can help make a busine
News
June 1, 2017 – Blue Bell, Pennsylvania – Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma Group
News
Friend of the Sea recognizes KD Pharma Groups leadership in sustainable sourcing
Geneva Switzerland – May 10, 2017. Friend of the Sea certification program contributes to the health
News
Geneva Switzerland – May 9 2017 Marine Ingredients, A KD Pharma Group company announced today at the VitaFoods Exhibition in Switzerland that it has expanded its organization to support the global
